Literature DB >> 16931775

Successful therapy must eradicate cancer stem cells.

David Dingli1, Franziska Michor.   

Abstract

Despite significant improvements in cancer therapy, tumor recurrence is frequent and can be due to a variety of mechanisms, including the evolution of resistance and tumor progression. Cancer stem cells have been postulated to maintain tumor growth similar to normal stem cells maintaining tissue homeostasis. Recently, the existence of these malignant stem cells has been proven for hematological as well as some solid tumors. Tumor stem cells are not targeted by standard therapy and might be responsible for treatment failure and tumor recurrence in many patients. We designed a simple mathematical model to demonstrate the importance of eliminating tumor stem cells. We explored different therapeutic scenarios to illustrate the properties required from novel therapeutic agents for successful tumor treatment. We show that successful therapy must eradicate tumor stem cells.

Entities:  

Mesh:

Year:  2006        PMID: 16931775     DOI: 10.1634/stemcells.2006-0136

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  78 in total

1.  Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia.

Authors:  Dana Paquin; Peter S Kim; Peter P Lee; Doron Levy
Journal:  Bull Math Biol       Date:  2010-06-09       Impact factor: 1.758

Review 2.  Building muscle: molecular regulation of myogenesis.

Authors:  C Florian Bentzinger; Yu Xin Wang; Michael A Rudnicki
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

3.  Extinction models for cancer stem cell therapy.

Authors:  Mary Sehl; Hua Zhou; Janet S Sinsheimer; Kenneth L Lange
Journal:  Math Biosci       Date:  2011-10-06       Impact factor: 2.144

4.  Eradication of melanomas by targeted elimination of a minor subset of tumor cells.

Authors:  Patrick Schmidt; Caroline Kopecky; Andreas Hombach; Paola Zigrino; Cornelia Mauch; Hinrich Abken
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 5.  Targeting cancer stem cells with oncolytic virus.

Authors:  Yin Tong; Wenbin Qian
Journal:  Stem Cell Investig       Date:  2014-11-28

Review 6.  Breast cancer stem cells-research opportunities utilizing mathematical modeling.

Authors:  Rina Ashkenazi; Trachette L Jackson; Gabriela Dontu; Max S Wicha
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

7.  Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.

Authors:  Rina Ashkenazi; Sara N Gentry; Trachette L Jackson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.

Authors:  Sreelatha Gopinath; Ramarao Malla; Kiranmai Alapati; Bharathi Gorantla; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

9.  Composite fatty acid ether amides suppress growth of liver cancer cells in vitro and in an in vivo allograft mouse model.

Authors:  Mengde Cao; Victor Prima; David Nelson; Stanislav Svetlov
Journal:  Cell Oncol (Dordr)       Date:  2013-04-26       Impact factor: 6.730

10.  Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.

Authors:  Jasmine Foo; Mark W Drummond; Bayard Clarkson; Tessa Holyoake; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2009-09-11       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.